Crosslinked Hydrogel Retinal Graft for Stable RPE Integration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for corneal blindness and retinal degenerative diseases, such as Age-related Macular Degeneration (AMD), face challenges including scarcity of corneal tissue donors, fragility of corneal implants, and inefficiencies in cell therapy delivery, leading to low success rates and risks of tissue damage and unwanted cell distribution.
Innovation Solution
Development of a retinal graft or implant comprising a scaffold made of protein or synthetic materials with matured retinal pigment epithelium (RPE) cells, which are fully differentiated and polarized, reducing the risk of cell loss and distribution issues, and an artificial endothelial keratoplasty graft with a crosslinked hydrogel support layer for improved mechanical properties and ease of implantation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If native DMEK graft is used, then rejection rate is lower and visual acuity is higher, but the graft tends to break easily during implantation and requires special techniques and experienced surgeons
Solution Approach 1:
The patent modifies the mechanical parameters of the DMEK graft by introducing crosslinking agents (such as riboflavin with UV light or chemical crosslinkers) to increase the stiffness and structural integrity of the Descemet membrane. This allows the graft to maintain its biological advantages while becoming sufficiently rigid for standard implantation techniques without requiring special handling or highly experienced surgeons.
Solution Approach 2:
The invention creates a composite structure by combining the native Descemet membrane with crosslinked polymer networks. This composite material retains the biological compatibility and low immunogenicity of the native tissue while incorporating the mechanical strength and stability of synthetic crosslinked structures, thereby resolving the contradiction between graft fragility and implantation ease.
2Strength
If doctors prefer stiffer graft from older donors, then mechanical strength is improved, but corneal endothelial cells are in lower density and conditions
Solution Approach 1:
The patent applies crosslinking technology to alter the mechanical parameters of the graft independently of donor age. By controlling the crosslinking degree and distribution, the graft can achieve the desired stiffness for easy implantation while preserving the high endothelial cell density and quality that would otherwise require selection from younger donors. This decouples the relationship between mechanical strength and cell quality.
3Reliability
If corneal tissue is harvested within several hours of death and transplanted within a few days, then tissue quality is maintained, but the time frame is quite short and tissue scarcity remains
Solution Approach 1:
The crosslinking process is performed on the corneal graft during the preparation phase, before implantation. This preliminary structural reinforcement allows the tissue to be stored for extended periods without degradation of mechanical properties, thereby extending the viable time frame for donation and transplantation while maintaining tissue quality. It also reduces the urgency of the transplantation timeline.
4Ease of operation
If cell suspension injection is used for RPE therapy, then delivery is simplified, but there is risk of unwanted distribution of cells within the eye
Solution Approach 1:
The patent segments the RPE cell delivery system by attaching cells to a structured scaffold or carrier device rather than injecting them as free suspension. This segmentation allows the cells to be delivered as a controlled unit, maintaining the simplicity of injection-based delivery while preventing unwanted dispersion. The scaffold structure confines the cells to the intended implantation site, ensuring proper distribution.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution provides a reliable source for thin, stiff corneal implants with healthy endothelial cells and enhances the integration of RPE cells in the eye, improving vision and reducing the risk of complications associated with existing treatments.
Implementation Method 1
an artificial endothelial keratoplasty graft with a crosslinked hydrogel support layer for improved mechanical properties and ease of implantation
Data Source
AI summary
A method of manufacturing a retinal graft. The method includes: (a) preparing a scaffold material solution; (b) air-drying the scaffold material solution, to form a thin scaffold layer; (c) crosslinking the thin scaffold layer; (d) rehydrating the scaffold layer; and (e) applying retinal pigment epithelium cells onto the scaffold layer.